Statin side-effects 'are widespread'

Thirty per cent of patients taking statins will suffer side-effects, a leading GP has claimed.

The latest claims come as researchers at the University of Nottingham announce that they are to begin a two-year study into the safety of statins.

Speaking at the Primary Care Live conference in London last week, Dr Malcolm Kendrick, a GP in Cheshire, said he had taken part in a Dutch investigation involving 7,000 patients on statins which found 30 per cent had suffered some side-effects.

But Dr Anthony Wierzbicki, a consultant in chemical pathology and director of the lipid unit at Guy's and St Thomas' Hospitals, London, dismissed the claims. 'We have no intention of canning statins because they work. They are the best drugs that we currently have to reduce cardiovascular risk.

'All drugs have side-effects - that is why they are regulated - but it is about weighting benefits against risks,' he said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

Doctors who rejoined the NHS workforce in the pandemic must be urged to stay to help...

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GP practices are unlikely to receive stocks of COVID-19 vaccine 'for at least another...

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...